Patients receiving b12 for pernicious anemia, neurological conditions, or documented deficiency do not report nausea improvement unless their nausea stemmed from the deficiency itself
In May 2024, 6% of adults said they were currently taking a GLP-1
Therapeutic potential of glucagon-like peptide-1 agonists in polycystic ovary syndrome: from current clinical evidence to future perspectives
Your clinician should talk you through potential next steps, which may be menopause care, joint evaluation, a gastrointestinal workup, physical therapy, or other forms of evidence-backed treatment
This once-weekly injection targets two hormones, GLP-1 and GIP
This finding offers novel insight into thyroid carcinoma patient demographics and new potential for possible prognosticator exploration